GLENVIEW CAPITAL MANAGEMENT, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001138995

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 45 positions · Total reported value $5.72B · Top-10 concentration 63.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 87.1% · 103 new · 16 cut · 9 exited

Active Share (vs S&P 500): 86.9% · vs QQQ: 85.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +1.7% · vs SPY -0.4% · Prev Value $5.23B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +1.8% · vs SPY -0.4% · Latest Value $5.56B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC disclosed 45 equity positions with a combined reported value of $5.72B. The filing implies a focused portfolio: its ten largest positions account for 63.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were THC ($665.05M), CI ($534.46M), CTVA ($391.36M). By sector, the heaviest allocations are Health Care 40.3%, Consumer Discretionary 20.0%. Versus the prior quarter, allocation shifted toward Health Care (+4.5pp), Consumer Staples (+1.8pp) and away from Communication Services (-1.2pp), Consumer Discretionary (-2.6pp).

Versus the prior quarter, GLENVIEW CAPITAL MANAGEMENT, LLC opened 103 new positions, trimmed 16 and fully exited 9, a turnover rate of 87.1% of positions. The portfolio's overlap with the prior quarter was 79% of names.

The largest new positions opened in Q1 2024 were SPY ($345.23M), ARRY ($32.87M), DNA ($27.84M).

Of the 9 positions fully exited versus the prior quarter, the largest were CHTR ($45.45M), CAH ($20.49M), INTC ($17.30M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • SPY STATE STR SPDR S&P 500 ETF T · $345.23M
  • ARRY ARRAY TECHNOLOGIES INC · $32.87M
  • DNA GINKGO BIOWORKS HOLDINGS INC · $27.84M
  • AVGO BROADCOM INC · $26.54M
  • CAR AVIS BUDGET GROUP INC · $22.16M
  • EXAS EXACT SCIENCES CORP COM · $15.72M
  • W WAYFAIR INC · $14.91M

Fully Exited (vs previous quarter)

  • CHTR CHARTER COMMUNICATIONS INC · prev qtr: $45.45M
  • CAH CARDINAL HEALTH INC · prev qtr: $20.49M
  • INTC INTEL CORP · prev qtr: $17.30M

Insider Transactions (Form 4)

Latest GLENVIEW CAPITAL MANAGEMENT, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Glenview Capital Management is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 138 US equity positions with a combined value of $5.56B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73695 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $6.37B as of 2026-09-15
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 6 private funds, of which 6 hedge funds

Portfolio Structure

  • 138 positions · $5.56B reported value (Q3 2026)
  • Top 10 holdings = 58.3% of reported value
  • Largest position: GPN (GLOBAL PMTS INC) at 10.4%
  • Average position size: $40.30M

Sector Tilt

  • Health Care 27.8%
  • Consumer Discretionary 24.5%
  • Industrials 21.7%
  • (classified holdings cover 92% of value)

Quarterly Activity

  • Q3 2026: 103 new, 16 added, 16 reduced, 9 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.33M $665.05M 11.63%
11.63%
Reduce
2 1.47M $534.46M 9.35%
9.35%
Add
3 6.79M $391.36M 6.84%
6.84%
Add
4 2.05M $374.87M 6.55%
6.55%
Add
5 660.00K $345.23M 6.04%
6.04%
New
6 2.39M $319.21M 5.58%
5.58%
Add
7 28.32M $279.00M 4.88%
4.88%
Add
8 12.78M $271.13M 4.74%
4.74%
Reduce
9 1.16M $242.96M 4.25%
4.25%
Reduce
10 8.36M $208.80M 3.65%
3.65%
Add
11 24.65M $183.16M 3.20%
3.20%
Hold
12 287.96K $154.59M 2.70%
2.70%
Reduce
13 2.52M $136.23M 2.38%
2.38%
Add
14 1.70M $135.31M 2.37%
2.37%
Add
15 802.69K $128.29M 2.24%
2.24%
Reduce
16 7.50M $105.84M 1.85%
1.85%
Add
17 4.94M $105.40M 1.84%
1.84%
Reduce
18 1.37M $97.15M 1.70%
1.70%
Add
19 14.44M $95.48M 1.67%
1.67%
Reduce
20 174.23K $90.34M 1.58%
1.58%
Add
21 1.13M $86.91M 1.52%
1.52%
Reduce
22 614.44K $84.64M 1.48%
1.48%
Reduce
23 1.33M $72.90M 1.27%
1.27%
Add
24 1.63M $72.83M 1.27%
1.27%
Reduce
25 402.94K $72.68M 1.27%
1.27%
Reduce
26 195.59K $65.23M 1.14%
1.14%
Reduce
27 5.14M $61.40M 1.07%
1.07%
Reduce
28 109.29K $53.07M 0.93%
0.93%
Reduce
29 480.52K $46.38M 0.81%
0.81%
Add
30 3.61M $36.24M 0.63%
0.63%
Reduce
31 2.20M $32.87M 0.57%
0.57%
New
32 24.00M $27.84M 0.49%
0.49%
New
33 20.03K $26.54M 0.46%
0.46%
New
34 5.95M $26.47M 0.46%
0.46%
Add
35 180.98K $22.16M 0.39%
0.39%
New
36 227.56K $15.72M 0.28%
0.28%
New
37 219.71K $14.91M 0.26%
0.26%
New
38 883.12K $12.82M 0.22%
0.22%
Add
39 8.03M $8.68M 0.15%
0.15%
Hold
40 291.86K $7.93M 0.14%
0.14%
Hold
41 176.11K $2.98M 0.05%
0.05%
Hold
42 116.47K $2.62M 0.05%
0.05%
Hold
43 1.32M $1.28M 0.02%
0.02%
Hold
44 1.71M $77.27K 0.00%
0.00%
Hold
45 15.99K $72.61K 0.00%
0.00%
Hold

FAQ

What did GLENVIEW CAPITAL MANAGEMENT, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, GLENVIEW CAPITAL MANAGEMENT, LLC reported 45 equity positions worth $5.72B in aggregate; its largest disclosed positions were THC ($665.05M), CI ($534.46M), CTVA ($391.36M).

How large is GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio?

GLENVIEW CAPITAL MANAGEMENT, LLC reported $5.72B of long equity holdings across 45 positions as of 2024-Q1. Top-10 holdings account for 63.5% of reported value.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/glenview-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →